Perhaps now more than ever, it is undeniable how integral vaccines have become to public health. Vaccines protect us from a whole host of infectious diseases, including chickenpox, measles and the seasonal flu. With a new threat at hand, scientists at the NIH swiftly developed a vaccine candidate against the novel coronavirus that causes COVID-19. The pre-clinical effort was driven in part by Dr. Kizzmekia Corbett.
Dr. Corbett is a viral immunologist and research fellow in the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID). Learn more about the work taking place at the VRC at https://www.niaid.nih.gov/about/vrc
Podden och tillhörande omslagsbild på den här sidan tillhör The Intramural Research Program of the National Institutes of Health (NIH). Innehållet i podden är skapat av The Intramural Research Program of the National Institutes of Health (NIH) och inte av, eller tillsammans med, Poddtoppen.
